Newsbenzinga
Reported Earlier, Xenon Pharmaceuticals CEO Ian Mortimer Buys 30K Shares At Average Price Of $37.38/Share; CFO Thomas Kelly Purchases 15K Shares At Average Price $37.32/Share
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…